These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 11461177

  • 1. Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1?
    Akalin I, Güllü IH, Kurdoglu M, Marangoz S.
    Med Hypotheses; 2001 Aug; 57(2):221-3. PubMed ID: 11461177
    [Abstract] [Full Text] [Related]

  • 2. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
    Kurdoglu M, Güllü IH, Akalin I.
    Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
    [Abstract] [Full Text] [Related]

  • 3. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [Abstract] [Full Text] [Related]

  • 4. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR, Kim CH.
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [Abstract] [Full Text] [Related]

  • 5. Elevation of type V collagen-degrading enzyme activity in invasive hepatocellular carcinoma.
    Kobayashi M, Watanabe A, Nakatsukasa H, Nagashima H.
    Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):143-4. PubMed ID: 2829327
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma.
    Liu Z, Yan L, Xiang T, Jiang L, Yang B.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):249-50, 254. PubMed ID: 12856590
    [Abstract] [Full Text] [Related]

  • 7. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y, Koda M, Murawaki Y.
    Res Commun Mol Pathol Pharmacol; 2004 Jun; 115-116():143-50. PubMed ID: 17564313
    [Abstract] [Full Text] [Related]

  • 8. Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells.
    Hwang ES, Lee HJ.
    J Nutr Biochem; 2006 Dec; 17(12):837-46. PubMed ID: 16563723
    [Abstract] [Full Text] [Related]

  • 9. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY, Park YN, Kim H, Park C.
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [Abstract] [Full Text] [Related]

  • 10. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.
    Matsumoto E, Nakatsukasa H, Nouso K, Kobayashi Y, Nakamura S, Suzuki M, Takuma Y, Tanaka H, Fujikawa T, Shiratori Y.
    Liver Int; 2004 Aug; 24(4):379-83. PubMed ID: 15287862
    [Abstract] [Full Text] [Related]

  • 11. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, Jechlinger M, Waerner T, Weith A, Beug H, Mikulits W.
    Oncogene; 2006 May 25; 25(22):3170-85. PubMed ID: 16607286
    [Abstract] [Full Text] [Related]

  • 12. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
    Hwang ES, Lee HJ.
    Food Chem Toxicol; 2008 Jul 25; 46(7):2358-64. PubMed ID: 18502015
    [Abstract] [Full Text] [Related]

  • 13. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.
    Hsu YL, Kuo PL, Cho CY, Ni WC, Tzeng TF, Ng LT, Kuo YH, Lin CC.
    Food Chem Toxicol; 2007 Jul 25; 45(7):1249-57. PubMed ID: 17316946
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
    Kaneko F, Saito H, Saito Y, Wakabayashi K, Nakamoto N, Tada S, Suzuki H, Tsunematsu S, Kumagai N, Ishii H.
    Int J Oncol; 2004 Apr 25; 24(4):837-45. PubMed ID: 15010820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.
    Jia WD, Sun HC, Zhang JB, Xu Y, Qian YB, Pang JZ, Wang L, Qin LX, Liu YK, Tang ZY.
    Cancer Lett; 2007 Mar 18; 247(2):234-42. PubMed ID: 16806673
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro.
    Xia D, Yan LN, Xie JG, Tong Y, Yan ML, Wang XP, Zhang MM, Zhao LY.
    Hepatobiliary Pancreat Dis Int; 2006 Aug 18; 5(3):409-15. PubMed ID: 16911941
    [Abstract] [Full Text] [Related]

  • 18. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.
    Jan YJ, Ko BS, Hsu C, Chang TC, Chen SC, Wang J, Liou JY.
    Hum Pathol; 2009 Oct 18; 40(10):1384-90. PubMed ID: 19454363
    [Abstract] [Full Text] [Related]

  • 19. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 20. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
    Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM, Mi L, Wen N, Tian R, Wang L, Yao H, Feng Q, Zhang Y, Xing JL, Zhu P, Chen ZN.
    Mol Cancer Res; 2007 Jun 15; 5(6):605-14. PubMed ID: 17579119
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.